2hp4
From Proteopedia
(New page: 200px<br /> <applet load="2hp4" size="450" color="white" frame="true" align="right" spinBox="true" caption="2hp4, resolution 2.10Å" /> '''Computational desig...) |
|||
Line 1: | Line 1: | ||
- | [[Image:2hp4. | + | [[Image:2hp4.jpg|left|200px]]<br /><applet load="2hp4" size="350" color="white" frame="true" align="right" spinBox="true" |
- | <applet load="2hp4" size=" | + | |
caption="2hp4, resolution 2.10Å" /> | caption="2hp4, resolution 2.10Å" /> | ||
'''Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor'''<br /> | '''Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor'''<br /> | ||
Line 8: | Line 7: | ||
==Disease== | ==Disease== | ||
- | Known | + | Known diseases associated with this structure: CD8 deficiency, familial OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=186910 186910]], Megakaryoblastic leukemia, acute OMIM:[[http://www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=606078 606078]] |
==About this Structure== | ==About this Structure== | ||
- | 2HP4 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with SO4 and GOL as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http:// | + | 2HP4 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with <scene name='pdbligand=SO4:'>SO4</scene> and <scene name='pdbligand=GOL:'>GOL</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2HP4 OCA]. |
==Reference== | ==Reference== | ||
Line 34: | Line 33: | ||
[[Category: soluble protein]] | [[Category: soluble protein]] | ||
- | ''Page seeded by [http:// | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 17:33:02 2008'' |
Revision as of 15:33, 15 February 2008
|
Computational design and crystal structure of an enhanced affinity mutant human CD8-alpha-alpha co-receptor
Contents |
Overview
Human CD8 is a T cell coreceptor, which binds to pHLA I and plays a, pivotal role in the activation of cytotoxic T lymphocytes. Soluble, recombinant CD8 alphaalpha has been shown to antagonize T cell activation, both in vitro and in vivo. However, because of a very low affinity for, pHLA I, high concentrations of soluble CD8 alphaalpha are required for, efficient inhibition. Based upon our knowledge of the wild-type CD8/pHLA I, structure, we have designed and produced a mutated form of soluble CD8, alphaalpha that binds to pHLA I with approximately fourfold higher, affinity. We have characterized the binding of the high affinity CD8, mutant using surface plasmon resonance and determined its structure at 2.1, A resolution using X-ray crystallography. The analysis of this structure, suggests that the higher affinity is achieved by providing a larger side, chain that allows for an optimal contact to be made between the HLA alpha3, loop and the mutated CDR-like loops of CD8. Proteins 2007. (c) 2007, Wiley-Liss, Inc.
Disease
Known diseases associated with this structure: CD8 deficiency, familial OMIM:[186910], Megakaryoblastic leukemia, acute OMIM:[606078]
About this Structure
2HP4 is a Single protein structure of sequence from Homo sapiens with and as ligands. Full crystallographic information is available from OCA.
Reference
Computational design and crystal structure of an enhanced affinity mutant human CD8 alphaalpha coreceptor., Cole DK, Rizkallah PJ, Boulter JM, Sami M, Vuidepot AL, Glick M, Gao F, Bell JI, Jakobsen BK, Gao GF, Proteins. 2007 Jan 22;67(1):65-74. PMID:17243170
Page seeded by OCA on Fri Feb 15 17:33:02 2008
Categories: Homo sapiens | Single protein | Boulter, J.M. | Cole, D.K. | Gao, G.F. | Glick, M. | Jakobsen, B.K. | Rizkallah, P.J. | GOL | SO4 | Cd8 | Co-receptor | Crystal structure | Immune-suppressor | Immunotherapy | Kd | Protein engineering | Soluble protein